Dsc Advisors, L.P. Global Blood Therapeutics, Inc. Transaction History

Dsc Advisors, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $637,000 - $933,500	25,000 Added 18.52%	160,000 $4.08 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $43.42 $2.11 Million - $2.82 Million	65,000 Added 92.86%	135,000 $4.73 Million
Q1 2021 May 14, 2021	BUY	$38.94 - $50.85 $2.73 Million - $3.56 Million	70,000 New	70,000 $2.85 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Dsc Advisors, L.P., based on Form 13F filings with the SEC.

Stay updated on Dsc Advisors, L.P. with notifications on news.